Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Initial therapy for chronic myelogenous leukemia: playing the odds.

Initial therapy for chronic myelogenous leukemia: playing the odds. J Clin Oncol. 1998 Sep; 16(9):2897-903.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.